Dr. Lal Pathlabs is currently trading at Rs. 1085.25, up by 15.45 points or 1.44% from its previous closing of Rs. 1069.80 on the BSE.
The scrip opened at Rs. 1110.00 and has touched a high and low of Rs. 1110.00 and Rs. 1085.00 respectively. So far 624 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1180.05 on 24-Jun-2019 and a 52 week low of Rs. 817.00 on 19-Nov-2018.
Last one week high and low of the scrip stood at Rs. 1110.00 and Rs. 1060.00 respectively. The current market cap of the company is Rs. 8915.89 crore.
The promoters holding in the company stood at 56.91%, while Institutions and Non-Institutions held 28.53% and 14.56% respectively.
Dr Lal Pathlabs has reported 14.83% rise in its net profit at Rs 57.30 crore for the quarter ended June 30, 2019 as compared to Rs 49.90 crore for the same quarter in the previous year. Total income of the company increased by 15.25% at Rs 338.60 crore for Q1FY20 as compared Rs 293.80 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 18.91% in its net profit at Rs 59.10 crore for the quarter ended June 30, 2019 as compared to Rs 49.70 crore for the same quarter in the previous year. Total income of the company increased by 15.88% at Rs 349.60 crore for Q1FY20 as compared Rs 301.70 crore for the corresponding quarter previous year.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8094.85 |
| Max Healthcare Inst | 1012.35 |
| Narayana Hrudayalay | 1819.75 |
| Aster DM Healthcare | 742.40 |
| Global Health | 1200.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: